CMO Robert Lechleider buys 15,805 shares at $9.48; 2 other insiders also bought in past 14 days
Robert Lechleider, Chief Medical Officer, purchased 15,805 shares at $9.48 on 2024-11-21, establishing his first position at this company. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The context is material: Immunome reported a net income of $-47,100,000.00 over its most recent full fiscal year, with the stock currently 59.2% below its 52-week high of $27.34. The cluster buying by multiple insiders during a period of unprofitability and significant price decline merits investor scrutiny into the underlying rationale and any non-public information that might have prompted coordinated accumulation at this level.